Solid-phase synthesis of 3,4-dihydroquinazoline

Tetrahedron Letters

Volumn 38, Issue 50, 1997, Pages 8651-8654

  Wang, Fengjiang ^a   Hauske, James R ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROQUINAZOLINE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; IN VITRO STUDY; REACTION ANALYSIS; TECHNIQUE;

EID: 0030784701     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)10377-X     Document Type: Article

References (24)

1. Reviews: (a) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. J. Med. Chem. 1994, 37, 1385.
2. (b) Ecker, D. J.; Crooke, S. T. Biotechnology 1995, 13, 351.
3. (c) Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele J. Tetrahedron 1995, 51, 8135.
4. Reviews: (a) Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996, 96, 555.
5. (b) Herkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron, 1996, 52, 4527.
6. (c) Früchtel, J. S.; Jung, G. Angew. Chem. Int. Ed. Engl. 1996, 35, 17.
7. (d) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449.
8. (e) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron, 1997, 53, 5643.
9. Reviews: (a) Wamhoff, H.; Richardt, G.; Stölben, S. Adv. Hetercycl. Chem. 1995, 64, 159.
10. (b) Molina, P.; Vilaplana, M. J. Synthesis 1994, 1197.
11. (c) Eguchi, S.; Matsushita, Y.; Yamashita, K. Org. Prep. Proced. Int. 1992, 24, 209.
12. (d) Barluenga, J.; Palacios, F. Org. Prep. Proced. Int. 1991, 23, 1.
13. (a) Staudinger, M.; Meyer, J. Helv. Chim. Acta. 1919, 49, 815.
14. (b) Review: Golologov, Y. G.; Kasukhin, L. F. Tetrahedron, 1992, 48, 1353.
15. (a) Drewry, D. H.; Gerritz, S. W.; Linn, J. A. Tetrahedron Lett. 1997, 38, 3377.
16. (b) Bittner, S.; Assaf, Y.; Krief, P.; Pomerantz, M.; Ziemnicka, B. T.; Smith, C. G. J. Org. Chem. 1985, 50, 1712.
17. 3P and DEAD in solution-phase also gave the corresponding aryl iminophosporane. This reaction, both in solution-phase and in solid-phase, has not been previously reported. See Reviews for Mitsunobu reaction: (a) Mitsunobu, O. Synthesis 1981, 1.
18. (b) Hughes, D. L. Org. React. 1992, 42, 335.
19. 3,4-Dihydroquinazolines may potentially have bioactivities: Ishikawa, F.; Watanabe, Y.; Saegusa, J. Chem Pharm. Bull. 1980, 28, 1357.
20. There are no reports describing the solid-phase synthesis of 3,4-dihydroquinazoline, although a solution-phase synthesis has been reported: Saito, T.; Tsuda, K.; Saito, Y. Tetrahedron Lett. 1996, 37, 209.
21. +).
22. Meyers, H. V.; Dilley, G. J.; Durgin, T. L.; Powers, T. S.; Winssinger, N. A.; Zhu, H.; Pavia, M. R. Molecular Diversity 1995, 1, 13.
23. Saito, T.; Nakane, M.; Endo, M.; Yamashita, H.; Oyamada, Y.; Motoki, S. Chem. Lett. 1986, 135.
24. The use of polymer bound carbodiimide as a coupling reagent for the formation of an amide bond has been previously reported: Desai, M. C.; Stramiello, L. M. S. Tetrahedron Lett. 1993, 34, 7685; structural determination was achieved by NMR and mass spectroscopy analyses.